Omega Healthcare Investors, Inc. Financial Ratios — OHI

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	5.74	12.77	14.93	16.39	8.74	9.65	2.71	8.05	9	3.99	10.76	11.36	6.74	10.02	12.15
Return on Assets (%)	2.16	4.36	5.35	6	3.77	4.33	1.13	3.24	3.71	1.65	4.36	4.48	2.61	4.27	5.92
Return on Capital (%)	6.05	8.61	8.59	9.8	6.97	6.47	3.63	5.59	6.04	3.98	6.87	7	5.19	6.64	8.11
Return on Invested Capital (%)	5.98	8.16	8.62	9.72	7.16	6.88	3.59	5.88	6.16	4.01	6.95	7.2	5.13	6.73	8
Gross Margin (%)	99.78	- -	- -	- -	- -	- -	100	100	98.39	98.62	98.85	98.24	98.42	98.62	98.79
EBITDA Margin (%)	81.5	93.58	94.18	92.82	83.64	91.81	66.36	88.34	91.88	80.29	93.46	114.3	83.24	89.43	93.66
Operating Margin (%)	56.58	61.68	63.61	69.91	65.42	64.17	61.49	60.14	59.68	50.68	53.27	44.67	51.48	62.74	62.51
Incremental Operating Margin (%)	43.38	87.21	73.54	100.59	55.92	58.25	- -	106.07	51.2	280.09	66.84	94.22	135.25	167.92	60.76
Pretax Margin (%)	18	34.44	41.2	43.85	31.54	42.66	11.66	33.63	37.02	18.19	39.15	49.66	26.92	40.02	52.47
Profit Margin (%)	18	34.44	41.2	43.85	30.19	40.68	11.05	31.94	36.73	17.85	39.21	48.61	25.5	38.65	49.59
Net Income to Common Margin (%)	17.42	34.44	41.2	43.85	30.19	40.68	11.05	31.94	36.73	17.85	39.21	48.61	25.5	38.65	49.59
Effective Tax Rate (%)	- -	- -	- -	- -	0.52	0.37	3.07	1.02	0.83	3.03	0.92	1.05	2.45	2.58	2.36
Dvd Payout Ratio (%)	314.65	150.95	126.43	116.78	147.96	113.2	459.41	172.67	155.5	364.99	144.96	140.41	252.09	159.67	124.12
Sustainable Growth Rate (%)	-12.32	-6.51	-3.95	-2.75	-4.19	-1.27	-9.74	-5.85	-5	-10.58	-4.84	-4.59	-10.25	-5.98	-2.93

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1,551	1,825	2,024	2,379	3,540	4,367	4,572	4,541	5,136	5,169	5,254	5,287	5,067	4,839	4,256
ST Debt	273	158	326	85	230	190	290	313	125	101	- -	19	20	- -	242
LT Debt	1,279	1,667	1,698	2,294	3,310	4,177	4,282	4,228	5,011	5,068	5,254	5,268	5,047	4,839	4,014
Total Debt/EBITDA	6.51	5.56	5.13	5.08	5.69	5.28	7.59	5.83	6.02	7.21	5.29	5.27	6.41	5.15	3.82
Net Debt/EBITDA	6.51	5.56	5.13	5.07	5.68	5.17	7.44	5.82	5.99	6.99	5.27	4.97	5.85	4.59	3.79
Total Debt/EBIT	11.26	8.49	7.62	6.89	8.61	7.8	14.51	9.13	9.31	13.37	8.07	7.87	10.76	7.61	5.39
Net Debt/EBIT	11.26	8.48	7.61	6.88	8.59	7.63	14.23	9.1	9.27	12.95	8.04	7.43	9.82	6.8	5.36
EBITDA to Interest Expense	2.74	3.09	4.28	3.69	3.39	4.71	2.74	3.87	4.09	3.21	4.23	4.3	3.36	4.24	5.18
EBITDA-CapEx/Interest Expense	1.74	3.09	4.28	3.69	2.5	4.32	2.34	3.17	3.42	2.87	3.83	4.3	3.36	4.24	5.18
EBIT to Interest Expense	1.9	2.04	2.89	2.78	2.66	3.29	2.54	2.63	2.66	2.02	2.41	1.68	2.08	2.98	3.46
Interest Expense	87	106	92	127	183	176	220	201	209	223	235	233	236	222	215
Common Equity/Total Assets	34.35	33.91	37.55	35.73	46.78	43.12	40.52	40.09	42.21	40.45	40.53	38.38	39.21	45.83	51.56
Long-Term Debt/Equity (%)	145.58	164.83	130.64	163.67	80.71	99.17	110.13	112.3	115.55	125.55	127.88	138.5	134.14	102.28	73.78
Long-Term Debt/Capital (%)	52.63	58.77	51.09	60.68	43.32	48.69	50.61	50.9	52.9	55.05	56.12	57.95	57.16	50.56	41.4
Long-Term Debt/Total Assets (%)	50.01	55.9	49.06	58.48	41.43	46.67	48.81	49.21	51.15	53.36	54.51	56.01	55.35	48.89	39.94
Total Debt/Equity (%)	176.6	180.45	155.71	169.73	86.32	103.68	117.59	120.62	118.44	128.06	127.88	139.01	134.69	102.28	78.23
Total Debt/Capital (%)	63.85	64.34	60.89	62.93	46.33	50.9	54.04	54.67	54.22	56.15	56.12	58.16	57.39	50.56	43.89
Total Debt/Total Assets (%)	60.67	61.2	58.47	60.65	44.31	48.8	52.11	52.85	52.43	54.43	54.51	56.21	55.58	48.89	42.35
Net Debt to Equity	176.56	180.28	155.51	169.41	86.19	101.45	115.38	120.34	117.88	124.01	127.38	131.2	122.92	91.33	77.73
Net Debt/Capital (%)	63.84	64.32	60.86	62.88	46.29	50.36	53.57	54.62	54.1	55.36	56.02	56.75	55.14	47.73	43.74
EBITDA	238	328	394	469	622	827	603	779	853	717	993	1,004	791	940	1,115
EBITDA-CapEx	151	328	394	469	458	758	516	639	714	641	898	1,004	791	940	1,115
Operating Income (Loss)	165	216	266	353	486	578	559	530	554	452	566	392	489	660	744

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.01	0.01	0.02	0.01	0.17	0.15	0.02	0.06	0.43	0.07	0.89	1.44	1.58	0.05
Current Ratio	0.94	1.33	2.06	6.18	2.66	2.98	2.56	2.06	2.82	3.64	6.53	5.3	7.25	8.03	3.46
Quick Ratio	0.85	1.2	1.99	6	2.62	2.86	2.4	2.05	2.79	3.42	5.78	5.26	7.03	7.77	3.41
CFO/Avg Current Liab	0.65	0.59	0.73	0.98	1.14	1.12	1.02	0.85	1.08	1.73	2.19	2.05	1.92	2.36	1.9
Common Equity/Total Assets	34.35	33.91	37.55	35.73	46.78	43.12	40.52	40.09	42.21	40.45	40.53	38.38	39.21	45.83	51.56
Long-Term Debt/Equity (%)	145.58	164.83	130.64	163.67	80.71	99.17	110.13	112.3	115.55	125.55	127.88	138.5	134.14	102.28	73.78
Long-Term Debt/Capital (%)	52.63	58.77	51.09	60.68	43.32	48.69	50.61	50.9	52.9	55.05	56.12	57.95	57.16	50.56	41.4
Long-Term Debt/Total Assets (%)	50.01	55.9	49.06	58.48	41.43	46.67	48.81	49.21	51.15	53.36	54.51	56.01	55.35	48.89	39.94
Total Debt/Equity (%)	176.6	180.45	155.71	169.73	86.32	103.68	117.59	120.62	118.44	128.06	127.88	139.01	134.69	102.28	78.23
Total Debt/Capital (%)	63.85	64.34	60.89	62.93	46.33	50.9	54.04	54.67	54.22	56.15	56.12	58.16	57.39	50.56	43.89
Total Debt/Total Assets (%)	60.67	61.2	58.47	60.65	44.31	48.8	52.11	52.85	52.43	54.43	54.51	56.21	55.58	48.89	42.35
CFO/Total Liabilities	10.11	10.57	12.95	13.39	11.56	13.19	11.83	10.35	10.14	12.97	13.06	11.17	11.54	14.5	19.06
CFO/CapEx	1.96	- -	- -	- -	2.74	9.06	6.67	3.58	3.96	9.43	7.6	- -	- -	- -	- -
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.98	1.05	1.72

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	3.02	3.14	3.16	3.31	4.16	4.23	3.59	2.88	2.54	2.84	4.37	4.05	4.7	4.35	4.36
Days Sales Outstanding	121.03	116.23	115.46	110.15	87.66	86.26	101.81	126.64	143.63	128.47	83.52	90.15	77.58	83.93	83.73
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8,269	7,924	12,915
- Cash & Cash Equivalents	- -	2	3	4	5	94	86	10	24	164	21	297	443	518	27
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	363	353	333	320	201	195	201	194	188	194	259
+ Total Debt	1,551	1,825	2,024	2,379	3,540	4,367	4,572	4,541	5,136	5,169	5,254	5,287	5,067	4,839	4,256
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13,082	12,438	17,403
Total Capital	2,430	2,836	3,325	3,780	7,641	8,579	8,460	8,305	9,473	9,206	9,362	9,090	8,830	9,570	9,697
Total Debt/Capital (%)	63.85	64.34	60.89	62.93	46.33	50.9	54.04	54.67	54.22	56.15	56.12	58.16	57.39	50.56	43.89
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.39	0.39	0.24
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.77	11.83	14.62
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.55	13.23	15.61
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.78	19.57	22.05
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.44	12.88	15.99
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.44	12.88	15.99
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8,444	7,677	13,326
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13,256	12,192	17,814
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	53.33	44.56	58.88
TTM Sales	292	350	419	505	744	901	908	882	929	892	1,063	878	950	1,051	1,190
TTM EBITDA	238	328	394	469	622	827	603	779	853	717	993	1,004	791	940	1,115
TTM Operating Income	165	216	266	353	486	578	559	530	554	452	566	392	489	660	744
TTM Cash Flow to Firm	257	314	372	464	632	800	791	699	761	925	955	857	848	965	1,089
TTM Free Cash Flow to Firm	170	314	372	464	467	731	705	559	621	850	860	857	848	965	1,089

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.67	10.24	15.17
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.78	19.57	22.05
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13,082	12,438	17,403
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.71	28.39	31.59
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.77	11.83	14.62
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.55	13.23	15.61
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.48	18.03	21.59
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.75	18.28	18.6
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	34.02	18.52	21.59
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.48	18.03	15.61
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.31	1.75	2.49
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.33	1.77	2.15
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.35	1.79	2.49
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.31	1.75	1.8
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.82	2.04	2.85
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.84	2.06	2.45
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.87	2.09	2.85
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.82	2.04	2.06
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.54	6.97	10.71
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.61	7.06	9.23
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.68	7.16	10.71
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.54	6.97	7.74
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.13	9.78	14.51
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.23	9.91	12.5
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.34	10.04	14.51
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.13	9.78	10.49
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.78	10.38	13.07
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.89	10.52	15.17
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.67	10.24	10.97
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.84	11.93	13.12
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.92	12.04	14.62
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.77	11.83	11.62
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.63	13.34	14.01
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.72	13.46	15.61
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.55	13.23	12.4
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.93	19.74	19.78
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.07	19.91	22.05
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.78	19.57	17.51
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.71	28.39	43.7
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	34.26	29.16	43.7
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13,149	12,546	15,614
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13,216	12,654	17,403
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13,082	12,438	13,825

Shares Outstanding	103	112	124	128	187	196	198	202	227	231	239	234	245	279	296
Diluted Weighted Avg Shares	102	108	118	127	181	202	207	210	222	235	244	244	250	270	305
Basic Weighted Avg Shares	102	108	117	127	172	192	198	200	213	228	237	236	240	258	292
Revenue per Share	2.86	3.26	3.57	3.99	4.32	4.7	4.59	4.4	4.35	3.92	4.49	3.72	3.95	4.07	4.08
EBITDA per Share	2.33	3.05	3.36	3.7	3.61	4.31	3.05	3.89	4	3.15	4.19	4.25	3.29	3.64	3.82
Operating Income per Share	1.62	2.01	2.27	2.79	2.82	3.01	2.82	2.65	2.6	1.99	2.39	1.66	2.03	2.56	2.55
Basic EPS, GAAP	0.5	1.12	1.47	1.75	1.3	1.91	0.51	1.41	1.6	0.7	1.76	1.81	1.01	1.57	2.02
Basic EPS from Cont Ops	0.52	1.12	1.47	1.75	1.35	2	0.53	1.47	1.65	0.72	1.81	1.86	1.03	1.62	2.09
Diluted EPS, GAAP	0.5	1.12	1.46	1.74	1.24	1.82	0.49	1.34	1.54	0.68	1.71	1.75	0.97	1.5	1.94
Diluted EPS from Cont Ops	0.51	1.12	1.46	1.74	1.29	1.9	0.51	1.4	1.58	0.7	1.75	1.8	0.99	1.54	2
Dividend per Share	1.59	1.69	1.86	2.04	2.08	2.36	2.54	2.64	2.64	2.69	2.69	2.68	2.68	2.66	2.68
Cash Flow per Share	1.66	1.94	2.39	2.67	2.61	3.26	2.92	2.49	2.59	3.11	3.05	2.65	2.57	2.9	3.01
Free Cash Flow per Basic Share	0.81	1.94	2.39	2.67	1.66	2.9	2.48	1.8	1.94	2.78	2.65	2.65	2.57	2.9	3.01
Cash & Equivalents per Share	- -	0.02	0.02	0.04	0.03	0.48	0.43	0.05	0.11	0.71	0.09	1.27	1.81	1.86	0.09
Book Value per Share	8.5	9	10.52	10.98	19.95	19.67	17.93	17.02	18.25	16.62	16.34	15.41	14.57	16.25	17.53
Tangible Book Value per Share	8.5	9	10.52	10.98	16.5	16.39	14.68	13.84	15.4	13.8	13.62	12.66	11.95	13.95	15.35

Omega Healthcare Investors, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)